• STAT+: Emergent was aware of vaccine manufacturing issues even as it collected $27 million a month from U.S

    30 days ago - By STAT

    Under a contract awarded by the Trump administration, Emergent BioSolutions was paid $27 million in monthly “reservation fees” to maintain its “readiness” to make Covid-19 vaccines, but the company was already aware of serious quality control problems at a Baltimore plant and had failed to take any action, according to documents released by two House committees.
    The manufacturing problems forced the company to destroy millions of doses of Johnson & Johnson Covid-19 vaccines earlier this year that were to have been made at the plant. In fact, a J&J audit conducted shortly after the contract...
    Read more ...